{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:37:51Z","timestamp":1788629871418,"version":"build-2803163510"},"reference-count":126,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Breast cancer stem-like cells (bCSCs) fundamentally represent a highly dynamic \u201cimmune-adaptive functional state\u201d rather than a fixed cellular lineage, serving as the core engine driving tumor recurrence, metastasis, and therapeutic resistance. Despite rapid advances, the heterogeneity of bCSC states and their intricate interactions with the immune microenvironment lack systematic integration. This review centers on the dynamic evolution and niche adaptation of bCSCs. First, we systematically dissect the multilayered regulatory network maintaining stemness, encompassing core transcription factors, epigenetic\u2013metabolic coupling, and the synergistic mechanisms of critical signaling pathways such as Wnt and Notch. Second, we propose a trinary \u201cstemness\u2013immune\u2013spatial\u201d feedback model, elucidating how bCSCs achieve active immune evasion by downregulating antigen presentation, secreting immunosuppressive factors, and embedding within perivascular \u201cimmune-cold niches.\u201d Finally, leveraging a multi-omics integration perspective, we reconstruct precision intervention strategies, exploring the synergistic potential of targeting stemness pathways in conjunction with immunotherapies like PD-1\/PD-L1 blockade and STING agonists. Furthermore, we highlight the pivotal role of integrating organoids, PDX models, and AI-assisted decision systems in overcoming heterogeneity and enabling personalized treatment. By establishing a closed-loop framework spanning mechanistic insight to spatially precise intervention, this review aims to provide novel theoretical foundations and translational pathways to surmount the bottleneck of therapeutic resistance in breast cancer.<\/jats:p>","DOI":"10.3390\/biom16050645","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:34:42Z","timestamp":1777458882000},"page":"645","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From State, Pathway, to Niche: The Ternary Network of Breast Cancer Stem-like Cells Driving Tumor Progression and Combination Therapy Prospects"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2228-8709","authenticated-orcid":false,"given":"Sitong","family":"Man","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, The First Hospital of China Medical University, Shenyang 110001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Hospital of China Medical University, Shenyang 110001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Hospital of China Medical University, Shenyang 110001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast Cancer: Pathogenesis and Treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering Breast Cancer: From Biology to the Clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cpt.2025.01.006","article-title":"Biomarkers, Isolation Methods, and Therapeutic Implications of Breast Cancer Stem Cells","volume":"3","author":"Teoh","year":"2025","journal-title":"Cancer Pathog. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Saha, T., and Lukong, K.E. (2022). Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.856974"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.7150\/ijbs.76187","article-title":"Targeting Breast Cancer Stem Cells","volume":"19","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.stem.2023.05.007","article-title":"IFN\u03b3-Induced Stem-like State of Cancer Cells as a Driver of Metastatic Progression Following Immunotherapy","volume":"30","author":"Beziaud","year":"2023","journal-title":"Cell Stem Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-024-01975-3","article-title":"LINC00115 Promotes Chemoresistant Breast Cancer Stem-like Cell Stemness and Metastasis through SETDB1\/PLK3\/HIF1\u03b1 Signaling","volume":"23","author":"Luo","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Olsson, M., Larsson, P., Johansson, J., Sah, V.R., and Parris, T.Z. (2023). Cancer Stem Cells Are Prevalent in the Basal-like 2 and Mesenchymal Triple-Negative Breast Cancer Subtypes in Vitro. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1237673"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","article-title":"Cancer Stem Cell Mimicry for Immune Evasion and Therapeutic Resistance","volume":"31","author":"Saw","year":"2024","journal-title":"Cell Stem Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.stemcr.2018.03.001","article-title":"Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling","volume":"10","author":"Colacino","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Qiu, J., Xu, L., Zeng, X., Wu, H., Liang, F., Lv, Q., and Du, Z. (2022). CCL5 Mediates Breast Cancer Metastasis and Prognosis through CCR5\/Treg Cells. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.972383"},{"key":"ref_12","first-page":"101005","article-title":"IFI30 Promotes Tumor-Associated Macrophage Infiltration via Activation of the ATF3-CCL5 Axis in Breast Cancer","volume":"6","author":"Ren","year":"2025","journal-title":"Innovation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer Stem Cells: Landscape, Challenges and Emerging Therapeutic Innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","article-title":"From Bulk, Single-Cell to Spatial RNA Sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int. J. Oral Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A Single-Cell and Spatially Resolved Atlas of Human Breast Cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13073-024-01407-3","article-title":"Integrated Single-Cell Analysis Reveals Distinct Epigenetic-Regulated Cancer Cell States and a Heterogeneity-Guided Core Signature in Tamoxifen-Resistant Breast Cancer","volume":"16","author":"Fang","year":"2024","journal-title":"Genome Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ciummo, S.L., D\u2019Antonio, L., Sorrentino, C., Fieni, C., Lanuti, P., Stassi, G., Todaro, M., and Di Carlo, E. (2021). The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.689286"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41423-024-01232-z","article-title":"Targeting of TAMs: Can We Be More Clever than Cancer Cells?","volume":"21","author":"Kzhyshkowska","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10238-025-01965-9","article-title":"AI-Driven Multi-Omics Integration in Precision Oncology: Bridging the Data Deluge to Clinical Decisions","volume":"26","author":"Hsu","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Abreu de Oliveira, W.A., El Laithy, Y., Bruna, A., Annibali, D., and Lluis, F. (2022). Wnt Signaling in the Breast: From Development to Disease. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.884467"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ros, M., Riesco-Llach, G., Polonio-Alcal\u00e1, E., Morla-Barcelo, P.M., Ruiz-Mart\u00ednez, S., Feliu, L., Planas, M., and Puig, T. (2024). Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137446"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nogueras P\u00e9rez, R., Heredia-Nicol\u00e1s, N., de Lara-Pe\u00f1a, L., L\u00f3pez de Andr\u00e9s, J., Marchal, J.A., Jim\u00e9nez, G., and Gri\u00f1\u00e1n-Lis\u00f3n, C. (2023). Unraveling the Potential of MiRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242116010"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13287-025-04218-4","article-title":"The Role of the MTOR Pathway in Breast Cancer Stem Cells (BCSCs): Mechanisms and Therapeutic Potentials","volume":"16","author":"Zhang","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12967-024-05281-w","article-title":"The Transcriptional Landscape of Cancer Stem-like Cell Functionality in Breast Cancer","volume":"22","author":"Baldasici","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1182\/blood-2009-10-247064","article-title":"Challenging the Adult T-Cell Leukemia\/Lymphoma (ATL) Stem Cell Concept Based on Limiting Dilution Transplantation Assay","volume":"115","author":"Bonnefoix","year":"2010","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ccell.2023.01.004","article-title":"Intratumoral CD8+ T Cells with a Tissue-Resident Memory Phenotype Mediate Local Immunity and Immune Checkpoint Responses in Breast Cancer","volume":"41","author":"Virassamy","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1038\/s41467-023-38097-1","article-title":"KK-LC-1 as a Therapeutic Target to Eliminate ALDH+ Stem Cells in Triple Negative Breast Cancer","volume":"14","author":"Bu","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Takchi, A., Zhang, M., Jalalirad, M., Ferre, R.L., Shrestha, R., Haddad, T., Sarkaria, J., Tuma, A., Carter, J., and David, H. (2024). Blockade of Tumor Cell-Intrinsic PD-L1 Signaling Enhances AURKA-Targeted Therapy in Triple Negative Breast Cancer. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1384277"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-22-0423","article-title":"JAK\u2013STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States","volume":"83","author":"Stevens","year":"2022","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Resendiz-Hern\u00e1ndez, M., Garc\u00eda-Hern\u00e1ndez, A.P., Silva-C\u00e1zares, M.B., Coronado-Uribe, R., Hern\u00e1ndez-de la Cruz, O.N., Arriaga-Pizano, L.A., Prieto-Ch\u00e1vez, J.L., Salinas-Vera, Y.M., Ibarra-Sierra, E., and Ortiz-Mart\u00ednez, C. (2024). MicroRNA-204 Regulates Angiogenesis and Vasculogenic Mimicry in CD44+\/CD24\u2212 Breast Cancer Stem-like Cells. ncRNA, 10.","DOI":"10.3390\/ncrna10010014"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Abdoli Shadbad, M., Hosseinkhani, N., Asadzadeh, Z., Derakhshani, A., Karim Ahangar, N., Hemmat, N., Lotfinejad, P., Brunetti, O., Silvestris, N., and Baradaran, B. (2021). A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24\u2212 Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.689839"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4048\/jbc.2015.18.3.242","article-title":"The Presence of EpCAM-\/CD49f+ Cells in Breast Cancer Is Associated with a Poor Clinical Outcome","volume":"18","author":"Ye","year":"2015","journal-title":"J. Breast Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e31970","DOI":"10.1016\/j.heliyon.2024.e31970","article-title":"Stem Cell Index-Based RiskScore Model for Predicting Prognosis in Thyroid Cancer and Experimental Verification","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wu, J., Liu, X., Huang, S., and Liu, W. (2025). Identification of a Cancer Stem Cell-Related Gene Signature in Hepatocellular Carcinoma Based on Single-Cell RNA-Seq and Bulk RNA-Seq Analysis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26072933"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"217409","DOI":"10.1016\/j.canlet.2024.217409","article-title":"Targeting UBE2T Suppresses Breast Cancer Stemness through CBX6-Mediated Transcriptional Repression of SOX2 and NANOG","volume":"611","author":"Wang","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/0008-5472.CAN-22-2682","article-title":"Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer","volume":"83","author":"Bassiouni","year":"2022","journal-title":"Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1038\/s41467-025-61034-3","article-title":"Integrative Spatial Omics Reveals Distinct Tumor-Promoting Multicellular Niches and Immunosuppressive Mechanisms in Black American and White American Patients with TNBC","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10232","DOI":"10.1038\/s41467-024-54145-w","article-title":"Spatial Transcriptomics Reveals Substantial Heterogeneity in Triple-Negative Breast Cancer with Potential Clinical Implications","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lai, J., Huang, R., and Huang, J. (2025). Stemness-Related Gene Signatures as a Predictive Tool for Breast Cancer Radiosensitivity. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1536284"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1186\/s12967-023-04679-2","article-title":"SIX1 Amplification Modulates Stemness and Tumorigenesis in Breast Cancer","volume":"21","author":"Guo","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1158\/0008-5472.CAN-21-1337","article-title":"ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","article-title":"Pan-Cancer Spatially Resolved Single-Cell Analysis Reveals the Crosstalk between Cancer-Associated Fibroblasts and Tumor Microenvironment","volume":"22","author":"Ma","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41586-023-06112-6","article-title":"Histone Modifications Regulate Pioneer Transcription Factor Cooperativity","volume":"619","author":"Sinha","year":"2023","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"216724","DOI":"10.1016\/j.canlet.2024.216724","article-title":"CD24 Negativity Reprograms Mitochondrial Metabolism to PPAR\u03b1 and NF-\u039aB-Driven Fatty Acid \u03b2-Oxidation in Triple-Negative Breast Cancer","volume":"587","author":"Murthy","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Venkatraman, S., Balasubramanian, B., Thuwajit, C., Meller, J., Tohtong, R., and Chutipongtanate, S. (2024). Targeting MYC at the Intersection between Cancer Metabolism and Oncoimmunology. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1324045"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12967-023-04204-5","article-title":"Cuproptosis Engages in C-Myc-Mediated Breast Cancer Stemness","volume":"21","author":"Wang","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer Stem Cells: Advances in Knowledge and Implications for Cancer Therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ju, Y., Xiao, W., Mathis, B.J., and Shi, Y. (2025). KLF4: A Multifunctional Nexus Connecting Tumor Progression and Immune Regulation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1514780"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"115561","DOI":"10.1016\/j.celrep.2025.115561","article-title":"Epigenomic Regulation of Stemness Contributes to the Low Immunogenicity of the Most Mutated Human Cancer","volume":"44","author":"Oka","year":"2025","journal-title":"Cell Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1111\/cas.16208","article-title":"A Comprehensive Overview of Metaplastic Breast Cancer: Features and Treatments","volume":"115","author":"Yan","year":"2024","journal-title":"Cancer Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-23-2390","article-title":"Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion","volume":"84","author":"Yan","year":"2024","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41419-021-03708-6","article-title":"A Novel Lnc408 Maintains Breast Cancer Stem Cell Stemness by Recruiting SP3 to Suppress CBY1 Transcription and Increasing Nuclear \u03b2-Catenin Levels","volume":"12","author":"Wen","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcancer.2021.03.008","article-title":"Novel Molecular Regulators of Breast Cancer Stem Cell Plasticity and Heterogeneity","volume":"82","author":"Zhang","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1038\/s41598-025-34163-4","article-title":"MiR-142-3p Targets the CXCL12\/WNT\/\u03b2-Catenin Pathway to Regulate the Stemness of Breast Cancer Cells","volume":"16","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12935-022-02527-9","article-title":"Tumor-Associated Macrophage Derived IL-6 Enriches Cancer Stem Cell Population and Promotes Breast Tumor Progression via Stat-3 Pathway","volume":"22","author":"Radharani","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"115921","DOI":"10.1016\/j.taap.2022.115921","article-title":"Indoleamine 2,3-Dioxygenase 1 Regulates Breast Cancer Tamoxifen Resistance through Interleukin-6\/Signal Transducer and Activator of Transcription","volume":"440","author":"Zhao","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41389-021-00310-5","article-title":"TGF\u03b2\/Cyclin D1\/Smad-Mediated Inhibition of BMP4 Promotes Breast Cancer Stem Cell Self-Renewal Activity","volume":"10","author":"Yan","year":"2021","journal-title":"Oncogenesis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e005543","DOI":"10.1136\/jitc-2022-005543","article-title":"Anti-TGF-\u03b2\/PD-L1 Bispecific Antibody Promotes T Cell Infiltration and Exhibits Enhanced Antitumor Activity in Triple-Negative Breast Cancer","volume":"10","author":"Yi","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-cancerbio-070620-103554","article-title":"TGF\u03b2: Signaling Blockade for Cancer Immunotherapy","volume":"6","author":"Chen","year":"2022","journal-title":"Annu. Rev. Cancer Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1038\/s41467-020-18860-4","article-title":"Jagged1-Notch1-Deployed Tumor Perivascular Niche Promotes Breast Cancer Stem Cell Phenotype through Zeb1","volume":"11","author":"Jiang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.7150\/thno.38875","article-title":"NOTCH4 Maintains Quiescent Mesenchymal-like Breast Cancer Stem Cells via Transcriptionally Activating SLUG and GAS1 in Triple-Negative Breast Cancer","volume":"10","author":"Zhou","year":"2020","journal-title":"Theranostics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1729299","DOI":"10.1080\/2162402X.2020.1729299","article-title":"PD-L1 Is Overexpressed on Breast Cancer Stem Cells through Notch3\/MTOR Axis","volume":"9","author":"Mansour","year":"2020","journal-title":"OncoImmunology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Tian, L.-Y., Smit, D.J., and J\u00fccker, M. (2023). The Role of PI3K\/AKT\/MTOR Signaling in Hepatocellular Carcinoma Metabolism. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032652"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCRESAHA.122.322113","article-title":"Liquid-Liquid Phase Separation of DDR1 Counteracts the Hippo Pathway to Orchestrate Arterial Stiffening","volume":"132","author":"Liu","year":"2023","journal-title":"Circ. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u039aB in Biology and Targeted Therapy: New Insights and Translational Implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13062-024-00460-7","article-title":"Unlocking Hepatocellular Carcinoma Aggression: STAMBPL1-Mediated TRAF2 Deubiquitination Activates WNT\/PI3K\/NF-Kb Signaling Pathway","volume":"19","author":"Wang","year":"2024","journal-title":"Biol. Direct"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-Associated Macrophages Restrict CD8+ T Cell Function through Collagen Deposition and Metabolic Reprogramming of the Breast Cancer Microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","article-title":"Cancer Cell-Derived Arginine Fuels Polyamine Biosynthesis in Tumor-Associated Macrophages to Promote Immune Evasion","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the Tumor Microenvironment and Mechanism of Immunotherapy-Based Drug Resistance in Breast Cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1158\/2326-6066.CIR-22-0296","article-title":"Breast Cancer Stem Cell\u2013Derived Tumors Escape from \u0393\u03b4 T-Cell Immunosurveillance In Vivo by Modulating \u0393\u03b4 T-Cell Ligands","volume":"11","author":"Raute","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e010179","DOI":"10.1136\/jitc-2024-010179","article-title":"Progesterone Receptor-Dependent Downregulation of MHC Class I Promotes Tumor Immune Evasion and Growth in Breast Cancer","volume":"13","author":"Tinoco","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/stem.2780","article-title":"Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion","volume":"36","author":"Sultan","year":"2018","journal-title":"Stem Cells"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e002899","DOI":"10.1136\/jitc-2021-002899","article-title":"Deregulation of HLA-I in Cancer and Its Central Importance for Immunotherapy","volume":"9","author":"Hazini","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"112613","DOI":"10.1016\/j.intimp.2024.112613","article-title":"CD44\/PD-L1-Mediated Networks in Drug Resistance and Immune Evasion of Breast Cancer Stem Cells: Promising Targets of Natural Compounds","volume":"138","author":"Malla","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Roqu\u00e9-Lloveras, A., P\u00e9rez-Bueno, F., Pozo-Ariza, X., Polonio-Alcal\u00e1, E., Ausell\u00e9-Bosch, S., Oliveras, G., Vi\u00f1as, G., and Puig, T. (2025). Breast Cancer Stem Cells and Immunogenicity Profile in High-Risk Early Triple-Negative Breast Cancer: A Pilot Study. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26093960"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13045-023-01487-5","article-title":"Synergistic Efficacy of Simultaneous Anti-TGF-\u03b2\/VEGF Bispecific Antibody and PD-1 Blockade in Cancer Therapy","volume":"16","author":"Niu","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"eadd5204","DOI":"10.1126\/sciimmunol.add5204","article-title":"Immunosuppressive Reprogramming of Neutrophils by Lung Mesenchymal Cells Promotes Breast Cancer Metastasis","volume":"8","author":"Gong","year":"2023","journal-title":"Sci. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Huang, P., Zhou, X., Zheng, M., Yu, Y., Jin, G., and Zhang, S. (2023). Regulatory T Cells Are Associated with the Tumor Immune Microenvironment and Immunotherapy Response in Triple-Negative Breast Cancer. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1263537"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-023-06511-9","article-title":"CD300ld on Neutrophils Is Required for Tumour-Driven Immune Suppression","volume":"621","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e31278","DOI":"10.1002\/jcp.31278","article-title":"Exploring the Interplay between Triple-negative Breast Cancer Stem Cells and Tumor Microenvironment for Effective Therapeutic Strategies","volume":"239","author":"Zou","year":"2024","journal-title":"J. Cell. Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","article-title":"PMN-MDSCs Modulated by CCL20 from Cancer Cells Promoted Breast Cancer Cell Stemness through CXCL2-CXCR2 Pathway","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., and Delort, L. (2023). Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044002"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"110255","DOI":"10.1016\/j.intimp.2023.110255","article-title":"The CD47-SIRP\u03b1 Axis Is a Promising Target for Cancer Immunotherapies","volume":"120","author":"Hao","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13058-025-02072-z","article-title":"MSN\/STAT3 Drives Cancer Stemness and Chemoresistance via IL-6\/LPAR1 Ligand Receptor Complex in Triple-Negative Breast Cancer","volume":"27","author":"Lee","year":"2025","journal-title":"Breast Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12964-021-00705-2","article-title":"Coordinated Regulation of Immune Contexture: Crosstalk between STAT3 and Immune Cells during Breast Cancer Progression","volume":"19","author":"Jin","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1038\/s41467-022-31250-2","article-title":"Breast Cancer Cell-Derived Extracellular Vesicles Promote CD8+\u2009T Cell Exhaustion via TGF-\u03b2 Type II Receptor Signaling","volume":"13","author":"Xie","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Wang, M., Yu, F., Zhang, Y., and Li, P. (2024). Novel Insights into Notch Signaling in Tumor Immunity: Potential Targets for Cancer Immunotherapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1352484"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Jiang, C., Sun, H., Jiang, Z., Tian, W., Cang, S., and Yu, J. (2024). Targeting the CD47\/SIRP\u03b1 Pathway in Malignancies: Recent Progress, Difficulties and Future Perspectives. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1378647"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Wang, Y., Li, J., Nakahata, S., and Iha, H. (2024). Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137346"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Zhang, M., Liu, C., Li, Y., Li, H., Zhang, W., Liu, J., Wang, L., and Sun, C. (2024). Galectin-9 in Cancer Therapy: From Immune Checkpoint Ligand to Promising Therapeutic Target. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1332205"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Xue, V.W., Chung, J.Y.-F., C\u00f3rdoba, C.A.G., Cheung, A.H.-K., Kang, W., Lam, E.W.-F., Leung, K.-T., To, K.-F., Lan, H.-Y., and Tang, P.M.-K. (2020). Transforming Growth Factor-\u03b2: A Multifunctional Regulator of Cancer Immunity. Cancers, 12.","DOI":"10.3390\/cancers12113099"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","article-title":"CellPhoneDB: Inferring Cell\u2013Cell Communication from Combined Expression of Multi-Subunit Ligand\u2013Receptor Complexes","volume":"15","author":"Efremova","year":"2020","journal-title":"Nat. Protoc."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","article-title":"NicheNet: Modeling Intercellular Communication by Linking Ligands to Target Genes","volume":"17","author":"Browaeys","year":"2019","journal-title":"Nat. Methods"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41576-020-00292-x","article-title":"Deciphering Cell\u2013Cell Interactions and Communication from Gene Expression","volume":"22","author":"Armingol","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1158\/0008-5472.CAN-23-1418","article-title":"Integration of Pan-Cancer Single-Cell and Spatial Transcriptomics Reveals Stromal Cell Features and Therapeutic Targets in Tumor Microenvironment","volume":"84","author":"Du","year":"2023","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Muralidharan, H., Hansen, T., Steinle, A., Schumacher, D., Stickeler, E., and Maurer, J. (2024). Breast Cancer Stem Cells Upregulate IRF6 in Stromal Fibroblasts to Induce Stromagenesis. Cells, 13.","DOI":"10.3390\/cells13171466"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41392-023-01453-0","article-title":"Extracellular Matrix-Derived Mechanical Force Governs Breast Cancer Cell Stemness and Quiescence Transition through Integrin-DDR Signaling","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/s41388-024-03127-9","article-title":"Mapping the Breast Tumor Microenvironment: Proximity Analysis Reveals Spatial Relationships between Macrophage Subtypes and Metastasis-Initiating Cancer Cells","volume":"43","author":"Grasset","year":"2024","journal-title":"Oncogene"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ccell.2024.05.004","article-title":"The Temporal Progression of Lung Immune Remodeling during Breast Cancer Metastasis","volume":"42","author":"McGinnis","year":"2024","journal-title":"Cancer Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/13543776.2021.1940138","article-title":"Recent Updates on Wnt Signaling Modulators: A Patent Review (2014-2020)","volume":"31","author":"Goswami","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"20224","DOI":"10.1073\/pnas.1314239110","article-title":"Targeting Wnt-Driven Cancer through the Inhibition of Porcupine by LGK974","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1158\/2767-9764.CRC-22-0106","article-title":"Inactivation of Notch4 Attenuated Pancreatic Tumorigenesis in Mice","volume":"2","author":"Saeki","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1158\/2159-8290.CD-23-0944","article-title":"Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3K\u03b1 Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia","volume":"14","author":"Varkaris","year":"2023","journal-title":"Cancer Discov."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular Matrix and Its Therapeutic Potential for Cancer Treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","article-title":"Signaling Pathways in Cancer-Associated Fibroblasts and Targeted Therapy for Cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"105320","DOI":"10.1016\/j.phrs.2020.105320","article-title":"Breast Cancer Stem Cells, Heterogeneity, Targeting Therapies and Therapeutic Implications","volume":"163","author":"Zeng","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41416-021-01389-8","article-title":"Phase 1 Study of Single-Agent WNT974, a First-in-Class Porcupine Inhibitor, in Patients with Advanced Solid Tumours","volume":"125","author":"Rodon","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ijc.33811","article-title":"Wnt Pathway Modulators in Cancer Therapeutics: An Update on Completed and Ongoing Clinical Trials","volume":"150","author":"Neiheisel","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e002627","DOI":"10.1136\/jitc-2021-002627","article-title":"Development of Preclinical and Clinical Models for Immune-Related Adverse Events Following Checkpoint Immunotherapy: A Perspective from SITC and AACR","volume":"9","author":"Bayless","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/imr.13240","article-title":"Mediators and Mechanisms of Immune Checkpoint Inhibitor-associated Myocarditis: Insights from Mouse and Human","volume":"318","author":"Gong","year":"2023","journal-title":"Immunol. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"101070","DOI":"10.1016\/j.pmatsci.2023.101070","article-title":"Nanoparticle Drug Delivery Systems and Their Applications as Targeted Therapies for Triple Negative Breast Cancer","volume":"134","author":"Kong","year":"2023","journal-title":"Prog. Mater. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1039\/D4NA00086B","article-title":"Cutting-Edge Approaches for Targeted Drug Delivery in Breast Cancer: Beyond Conventional Therapies","volume":"6","author":"Chaudhari","year":"2024","journal-title":"Nanoscale Adv."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Linde, C., Chien, Y.-T., Chen, Z., and Mu, Q. (2024). Nanoparticle-Enhanced PD-1\/PD-L1 Targeted Combination Therapy for Triple Negative Breast Cancer. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1393492"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Huang, T., Li, F., Cheng, X., Wang, J., Zhang, W., Zhang, B., Tang, Y., Li, Q., Zhou, C., and Tu, S. (2021). Wnt Inhibition Sensitizes PD-L1 Blockade Therapy by Overcoming Bone Marrow-Derived Myofibroblasts-Mediated Immune Resistance in Tumors. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.619209"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"eado8275","DOI":"10.1126\/sciadv.ado8275","article-title":"Inhibition of Notch Enhances Efficacy of Immune Checkpoint Blockade in Triple-Negative Breast Cancer","volume":"10","author":"Shen","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Chen, X., Feng, L., Huang, Y., Wu, Y., and Xie, N. (2022). Mechanisms and Strategies to Overcome PD-1\/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer. Cancers, 15.","DOI":"10.3390\/cancers15010104"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tcb.2022.06.010","article-title":"Targeting STING to Promote Antitumor Immunity","volume":"33","author":"Chin","year":"2023","journal-title":"Trends Cell Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41590-023-01671-2","article-title":"CD47 Masks Pro-Phagocytic Ligands in Cis on Tumor Cells to Suppress Antitumor Immunity","volume":"24","author":"Tang","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e120638","DOI":"10.1172\/jci.insight.120638","article-title":"A Nanoparticle-Incorporated STING Activator Enhances Antitumor Immunity in PD-L1\u2013Insensitive Models of Triple-Negative Breast Cancer","volume":"3","author":"Cheng","year":"2018","journal-title":"JCI Insight"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Mei, R., Wan, Z., Yang, C., Shen, X., Wang, R., Zhang, H., Yang, R., Li, J., Song, Y., and Su, H. (2024). Advances and Clinical Challenges of Mesenchymal Stem Cell Therapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1421854"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"115803","DOI":"10.1016\/j.bcp.2023.115803","article-title":"Breast Cancer Organoids Derived from Patients: A Platform for Tailored Drug Screening","volume":"217","author":"Tzeng","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/acsptsci.4c00597","article-title":"Nanoparticle-Mediated MRNA Delivery to Triple-Negative Breast Cancer (TNBC) Patient-Derived Xenograft (PDX) Tumors","volume":"8","author":"Manturthi","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Kametani, Y., Ito, R., Manabe, Y., Kulski, J.K., Seki, T., Ishimoto, H., and Shiina, T. (2024). PBMC-Engrafted Humanized Mice Models for Evaluating Immune-Related and Anticancer Drug Delivery Systems. Front. Mol. Biosci., 11.","DOI":"10.3389\/fmolb.2024.1447315"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","article-title":"Conserved Spatial Subtypes and Cellular Neighborhoods of Cancer-Associated Fibroblasts Revealed by Single-Cell Spatial Multi-Omics","volume":"43","author":"Liu","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e48568","DOI":"10.2196\/48568","article-title":"Utility of ChatGPT in Clinical Practice","volume":"25","author":"Liu","year":"2023","journal-title":"J. Med. Internet Res."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/5\/645\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:12:33Z","timestamp":1777461153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/5\/645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":126,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["biom16050645"],"URL":"https:\/\/doi.org\/10.3390\/biom16050645","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]}}}